BAI-3 Activators encompass a unique class of chemical compounds that serve to enhance the activity of Brain-specific Angiogenesis Inhibitor 3 (BAI-3), a protein encoded by the ADGRB3 gene. BAI-3 is part of the adhesion G protein-coupled receptor (GPCR) family, which plays a critical role in processes such as synapse formation, neural development, and angiogenesis. These activators function by binding to specific domains of BAI-3 or by influencing the cellular signaling pathways to which BAI-3 is integral. For instance, some activators may bind to the GPCR proteolytic site (GPS) of BAI-3, which is a critical region for its activation and subsequent signaling. By stabilizing the active conformation of BAI-3, these compounds can enhance its ability to mediate cell adhesion. Others might interact with the extracellular matrix and integrins, thereby facilitating the protein's role in neuron-neuron or neuron-glia interactions, which are essential for synaptic organization.
Additionally, certain BAI-3 Activators may indirectly promote BAI-3 activity by modulating intracellular signaling cascades that BAI-3 is known to influence. Some compounds may enhance the second messenger systems, such as cyclic AMP (cAMP), which further lead to the activation of protein kinase A (PKA) and other kinases that phosphorylate BAI-3, thus increasing its signaling efficacy. Other activators might work by altering the lipid composition of the neuronal membranes, which can affect the localization and function of BAI-3, leading to enhanced synaptic plasticity and neurogenesis. These chemical activators, through their precise and targeted actions, facilitate the biological functions of BAI-3 without altering its expression levels or requiring direct ligand binding. By doing so, they play a pivotal role in sustaining and regulating the physiological processes controlled by BAI-3, highlighting their significance in the fine-tuning of neural development and maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, as a tyrosine kinase inhibitor, reduces competitive phosphorylation from other tyrosine kinase pathways, which could result in a relative increase in signaling processes that specifically activate BAI-3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) engages S1P receptors that can activate G-protein coupled pathways, potentially altering the cellular environment in a way that enhances BAI-3 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Elevated calcium may activate calcium-dependent kinases and phosphatases that can indirectly upregulate BAI-3 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that mimics diacylglycerol (DAG). Activation of PKC can lead to altered phosphorylation states of proteins involved in signaling pathways that could enhance BAI-3 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may preferentially inhibit kinases competing with those that directly activate BAI-3, thereby selectively enhancing BAI-3-related signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can diminish PI3K/Akt signaling, potentially allowing for the redirection of signaling resources towards pathways that upregulate BAI-3 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that functions similarly to LY294002, potentially enhancing signaling pathways that activate BAI-3 by reducing PI3K/Akt pathway activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may shift signaling dynamics to favor pathways that activate BAI-3, as p38 MAPK inhibition can result in compensatory signaling through alternative pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Higher calcium can engage signaling proteins and pathways that amplify BAI-3 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, despite being a broad-spectrum kinase inhibitor, may preferentially inhibit kinases that negatively regulate pathways leading to BAI-3 activation, thereby indirectly enhancing BAI-3 signaling. | ||||||